Skip to main content
SpringerLink
Log in

Treatment of Paget’s Disease with the New Bisphosphonates

  • Chapter
Paget’s Disease of Bone

Abstract

The increased availability of the bisphosphonates over the past 15 years has revolutionized the medical treatment of Paget’s disease and also stimulated renewed interest in its surgical management. Etidronate is the most widely available bisphosphonate, and it is against a wide experience of this agent that new bisphosphonates are being evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gray RES, Yates AJP, Preston CJ, et al: Duration of effect of oral diphosphonate therapy in Paget’s disease of bone. Q J Med 1987; 64: 755–767.

    PubMed  CAS  Google Scholar 

  2. Russell RGG, Smith R, Preston C, et al: Diphosphonates in Paget’s disease. Lancet 1974; 1: 894–898.

    PubMed  CAS  Google Scholar 

  3. Canfield R, Rosner W, Skinner J, et al: Diphosphonate therapy of Paget’s disease of bone. J Clin Endocrinol Metab 1977; 44: 96–106.

    Article  PubMed  CAS  Google Scholar 

  4. Siris ES, Canfield RE, Jacobs TE, et al: Long-term therapy of Paget’s disease of bone with EHDP. Arthritis Rheum 1980; 23: 1177–1183.

    Article  PubMed  CAS  Google Scholar 

  5. Preston CJ, Yates AJP, Beneton MNC, et al: Effective short term treatment of Paget’s disease with oral etidronate. Br Med J 1986; 292: 79–80.

    Article  CAS  Google Scholar 

  6. Kanis JA, Urwin GH, Gray RES, et al: Effects of intravenous etidronate disodium on skeletal and calcium metabolism. Am J Med 1987; 82 (suppl 2A): 55–70.

    Article  PubMed  CAS  Google Scholar 

  7. Fleisch H: Experimental basis for the use of bisphosphonates in Paget’s disease of bone. Clin Orthop 1987; 217: 72–78.

    PubMed  Google Scholar 

  8. Fleisch H: Bisphosphonates: Mechanisms of action and clinical applications, in Peck WA (ed): Bone and Mineral Research Annual 1. Amsterdam, Excerpta Medica, 1989; pp 319–357.

    Google Scholar 

  9. Shinoda H, Adamek G, Felix R, et al: Structure-activity relationship of various bisphosphonates. Calcif Tissue Int 1983; 35: 87–99.

    Article  PubMed  CAS  Google Scholar 

  10. Yakatan GL, Poynor WJ, Talbert RL, et al: Clodronate kinetics and bioavailability. Clin Pharmacol Ther 1982, 31: 402–410.

    Article  PubMed  CAS  Google Scholar 

  11. Fogelman I, Smith L, Mazess R, et al: Absorption of oral diphosphonate in normal subjects. Clin Endocrinol 1986; 24: 57–62.

    Article  CAS  Google Scholar 

  12. Harinck HIJ, Bijvoet OLM, Blanksma HJ, Dahlinghaus-Nienhuys PJ: Efficacious management with aminobisphophonate (APD) in Paget’s disease of bone. Clin Orthop 1987; 217: 79–98.

    PubMed  Google Scholar 

  13. Michael WR, Kjfiìg WR, Wakim JM: Metabolism of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) in the rat, rabbit, dog, and monkey. Toxicol Appl Pharmacol 1972; 21: 503–515.

    Article  PubMed  CAS  Google Scholar 

  14. Yates AJP, Percival RC, Gray RES, et al: Intravenous clodronate in the treatment and retreatment of Paget’s disease of bone. Lancet 1985; 1: 474 - 477.

    Google Scholar 

  15. Atkins RM, Yates AJP, Gray RES, et al: Aminohexane disphosphonate in the treatment of Paget’s disease of bone. J Bone Mineral Res 1987; 2: 273 - 279.

    Article  CAS  Google Scholar 

  16. O’Docherty DP, Bickerstaff DR, McCloskey EV, et al: The treatment of Paget’s disease with aminobutylidene diphosphonate. J Bone Mineral Res In Press.

    Google Scholar 

  17. Delmas PD, Chapuy MC, Vignon E, et al: Long-term effects of dichloromethylene diphosphonate in Paget’s disease of bone. J Clin Endocrinol Metab 1982; 54: 837 - 844.

    Article  PubMed  CAS  Google Scholar 

  18. Meunier PJ, Saison C, Mathieu L, et al: Skeletal distribution of Paget’s disease. Clin Orthop 1987; 217: 37 - 44.

    PubMed  Google Scholar 

  19. Douglas DL, Duckworth T, Kanis JA, et al: Biochemical and clinical response to dichloromethylene diphosphonate (G2MDP) in Paget’s disease of bone. Arthritis Rheum 1980; 23: 1185 - 1192.

    Article  PubMed  CAS  Google Scholar 

  20. Meunier PJ, Alexandre C, Edouard C, et al: Effects of disodium dichloromethylene diphosphonate on Paget’s disease of bone. Lancet 1979; 2: 489–492.

    Article  PubMed  CAS  Google Scholar 

  21. Espinasse D, Mathieu L, Alexandre C, et al: The kinetics of 99mTc labelled EHDP in Paget’s disease before and after dichloromethylene-diphosphonate treatment. Metab Bone Dis 1981; 2: 321 - 324.

    Article  Google Scholar 

  22. Chapuy MC, Charon SA, Meunier PJ: Sustained biochemical effects of short treatment of Paget’s disease of bone with dichloromethylene diphosphonate. Metab Bone Dis 1983; 4: 325–328.

    CAS  Google Scholar 

  23. McCloskey EV, Yates AJP, Beneton MNC, et al: Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man. Bone 1987; 8 (suppl 1): 35–42.

    Google Scholar 

  24. Douglas DL, Duckworth T, Kanis JA, et al: Spinal cord dysfunction in Paget’s disease of bone: Has medical treatment a vascular basis? J Bone Joint Surg 1981;63-B:495–503.

    Google Scholar 

  25. Borgstrom GH, Elomaa I, Blomqvist C, Porkka L: Cytogenetic investigations of patients on clodronate therapy for Paget’s disease of bone. Bone 1987; 8 (suppl l): 85–86.

    Google Scholar 

  26. Reginster JY, Lecart MP, Deroisy R, et al: Treatment of Paget’s disease of bone with high oral doses of oral tiludronate given during a five-day course therapy. J Bone Mineral Res 1990; 5 (suppl 2): 170.

    Google Scholar 

  27. Papapoulos SE, Frolisch M, Hoekman K, Bijvoet OLM: Dimethyl-APD treatment modifies osteoblastic function in patients with Paget’s disease. Calcif Tissue Int 1989; 44(suppl):sl08.

    Google Scholar 

  28. Reginster JY, Jeugmans-Huynen AM, Albert A, et al: One year’s treatment of Paget’s disease of bone by synthetic salmon calcitonin as a nasal spray. J Bone Mineral Res 1988; 3: 249–252.

    Article  CAS  Google Scholar 

  29. Kanis JA, Heynen G, Paterson A, et al: Endogenous secretion of calcitonin in physiological and pathological conditions, in Pecile A (ed): Calcitonin. Amsterdam, Elsevier, 1985, pp 81–88.

    Google Scholar 

  30. Kanis JA, Gray RES, McCloskey EV: Treating Paget’s disease. Br Med J 1987; 294: 1612–1613

    Article  CAS  Google Scholar 

  31. Elomaa I, Blomqvist C, Grohn P, et al: Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases. Lancet 1983; 1: 146–149.

    Article  PubMed  CAS  Google Scholar 

  32. Siris ES, Hyman GA, Canfield RE: Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton. Am J Med 1983; 74: 401.

    Article  PubMed  CAS  Google Scholar 

  33. Dove J: Complete fractures of the femur in Paget’s disease of bone. J Bone Joint Surg 1980; 62B: 12–17.

    Google Scholar 

  34. Bowie HIC, Kanis JA: Calcitonin in the assessment and preparation of patients with Paget’s disease for surgery, in Kanis JA (ed): Bone Disease and Calcitonin. Eastbourne, England, Armour Pharmaceutical, 1977, pp 61–69.

    Google Scholar 

  35. Doyle FH, Banks LM, Pennock JM: Radiologic observations on bone resorption in Paget’s disease. Arthritis Rheum 1980; 23: 1205–1214.

    Article  PubMed  CAS  Google Scholar 

  36. Nagant de Deuxchaisnes C, Rombouts-Lindemans C, Huaux JP, et at: Treatment of Paget’s disease with the diphosphonate APD: A biological and radiological study, in Donath A, Courvoisier B (eds): Diphosphonates and Bone. Geneva, Editions Medicine et Hygiene, 1982, pp 303–327.

    Google Scholar 

  37. Altman RD: Long-term follow up of therapy with intermittent etidronate disodium in Paget’s disease of bone. Am J Med 1985; 79: 583–590.

    Article  PubMed  CAS  Google Scholar 

  38. Bickerstaff D, Douglas DL, Burke PH, et al: Improvement in facial deformity of Paget’s disease treated with diphosphonates. J Bone Joint Surg 1990; 728: 132–136.

    Google Scholar 

  39. Douglas DL, Ranis JA, Duckworth T, et al: Paget’s disease: Improvement of spinal cord dysfunction with diphosphonates and calcitonin. Metab Bone Dis 1981; 3: 327–336.

    Article  CAS  Google Scholar 

Download references

Authors
  1. John A. Kanis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eugene V. McCloskey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Declan O’Doherty
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Neveen A. T. Hamdy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Derek Bickerstaff
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Monique Beneton
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maniccam Thavarajah
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. UCLA School of Medicine, University of California at Los Angeles, USA

    Frederick R. Singer MD (Professor of Medicine in Residence, Director) (Professor of Medicine in Residence, Director)

  2. Bone Center, Cedars-Sinai Medical Center, 444 S. San Vicente Boulevard, 90048, Los Angeles, California, USA

    Frederick R. Singer MD (Professor of Medicine in Residence, Director) (Professor of Medicine in Residence, Director)

  3. Department of Internal Medicine, University of South Florida College of Medicine, 12901 North 30th Street, 33612-4799, Tampa, Florida, USA

    Stanley Wallach MD (Professor and Associate Chairman) (Professor and Associate Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Elsevier Science Publishing Co., Inc.

About this chapter

Cite this chapter

Kanis, J.A. et al. (1991). Treatment of Paget’s Disease with the New Bisphosphonates. In: Singer, F.R., Wallach, S. (eds) Paget’s Disease of Bone. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2307-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-2307-5_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-2309-9

  • Online ISBN: 978-1-4684-2307-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation